NCT06363981Recruiting
Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
Multisite Repetitive Transcranial Magnetic Stimulation for Mood, Cognitive Impairment, Anhedonia and Disordered Sleep in Depressive Disorder
Source: ClinicalTrials.gov · Last updated 15 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Depressed mood is the main symptom of depression, but other symptoms like cognitive impairment, anhedonia or sleep disorders may also contribute to patients suffering and are difficult to treat. rTMS is a relatively novel treatment option, whose therapeutic potential is still investigated and optimized. The aim of this study is to assess the effect of rTMS applied over two stimulation sites on cognitive impairment, anhedonia and sleep disorders in depression.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 9 Apr 2024
- Start date
- 20 May 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- Jakub Antczak
- Diseases
- Depression, Bipolar disorder
- NCT number
- NCT06363981
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 20 May 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Suicidal ideations and/or attempts within three months prior to inclusion
Other illness
- Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy
Other
- Psychotic symptoms at the time of inclusion
Who the study is looking for
- severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion
- Hamilton Depression Rating Scale between between 20 and 35 points at inclusion
- The score in the Athens Insomnia Scale eight or more
- The score of three or more points in items 4 and 21 of the Beck Depressions Inventory 2
- Complaining about problems with memory and concentration timely related with the onset of depression
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Education of Research and Development Center, Babinski Clinical Hospital Coordinator of this site? Confirm its status | Krakow | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.